SlideShare a Scribd company logo
Simplifying
Spirometry Dr KUMAR UTSAV MD
CLINICIAN
WHY DO WE NEED SPIROMETRY…
 Spirometry is a method of assessing lung
function by measuring the volume of air the
patient can expel from the lungs after a
maximal inspiration.
 A simple and safe test that measures lung
function with a graphical display.
What is Spirometry?
spirometry is like the
ECG of lungs
Eur Respir J 2005; 25:587-588
Level of FEV1 as a predictor of all-cause
and cardiovascular mortality: an effect
beyond smoking and physical fitness?
J. Sunyer1 and C. S. Ulrik2
LUNG HEALTH STUDY
Chest. 2005;127:1952-1959
The Relationship Between Reduced Lung
Function and Cardiovascular Mortality
A Population-Based Study
Don D. Sin, MD, MPH, FCCP; LieLing Wu, MSc and S. F. Paul Man, MD
Every 10% decrease in FEV1 leads to –
14% Increase in all cause mortality
28% increase in Cardio-Vascular mortality
COPD is powerful independent risk
factor for Cardio-Vascular mortality
LUNG HEALTH STUDY
In fact, approximately 50% patients of COPD
have ischemic heart disease as the primary
cause of hospitalization.
COPD & CVD:
Chest. 2005;127:1952-1959
LUNG HEALTH STUDY
Why should every doctor know
about spirometry?
More than half of the population of India
suffer from respiratory disease or are the
potential patients of these diseases
Therefore any doctor involved in care of
asthma, COPD or pulmonary fibrosis should
understand the basics of pulmonary function
testing
Why do physicians not do
spirometry ?
 Don’t ever think about it
 Too busy
 Feel the test is complex
 Don’t know what to ask for in the spirogram
 Time consuming
 Not cost effective
 Results don’t affect treatment
Indications
 Diagnosis of obstructive & restrictive lung diseases
 To screen people at risk of pulmonary diseases
 To assess preoperative risk
 To assess prognosis
 To assess therapeutic interventions
 To assess patients as part of a rehabilitation program
 Epidemiologic surveys for pulmonary diseases
Contraindications:
 Within 6 weeks since the last
exacerbation.
 Recent MI less than 3-6 months
ago.
 Unstable angina in last 24 hours.
 Haemoptysis of unknown origin.
 Recent eye surgery less than 3-6
months.
 Abdominal surgery within last 3-6
months.
 Recent CVA less than 3-6 months.
 Diagnosis of Tuberculosis unless special
precautions used.
 Current chest infection or within in last 6
weeks.
 Current chest pain with no diagnosis.
 Pulmonary embolism (PE) within last 3-6
months.
 Ear infection.
 Spontaneous pneumothorax.
 Aortic aneurysm.
DONT’S
 Smoking (1 hour prior)
 Consumption of alcohol (4 hours prior)
 Vigorous exercise (30 minutes prior)
 Wearing tight clothes.
 Eating a substantial meal (at least 2 hours prior)
 Test should be performed when the patient is
clinically stable and free from infection.
 Drinking fluids containing caffeine (12 hours prior)
Withholding bronchodilators
(ARTP)
Inhaled bronchodilators Duration of
action (hours)
Short-acting 4 to 8
Long-acting 24
Anticholinergics 6
Oral short-acting bronchodilators 8
Sustained release β2
agonists 24
Theophylline
Twice-daily preparations 24
Once-daily preparations 48
Definitions
 Forced Expiratory Manoeuvre (FEM)
The patient takes a maximal deep breath , then blows out as hard as
possible until the lungs feel completely empty. From this the following
parameters are calculated:
 FEV1
Volume of gas expired from the lungs in the 1st
second of a FEM
 FVC
Total volume of gas expired from the lungs during a FEM
 FER
FEV1/FVC
Spirometric
Interpretation
Interpretation of Spirometry
Step 1. Look at the Flow-Volume loop
Step 2. Look at FEV1/FVC ratio
Step 3. Look at FVC
Step 4. Look at FEV1 >75%
Step 5. Look at FEF25-75%
Criteria for Normal
Post-bronchodilator Spirometry
 FEV1: % predicted > 80%
 FVC: % predicted > 80%
 FEV1/FVC: > 70
Two basic types of pulmonary function
abnormalities are described using the basic
spirometric parameters:
Obstructive and Restrictive
Obstructive defects
 FEV1/ FVC Ratio < 70%
 FEV1 <80%(Post bronchodilator)
Mechanism Airway damage and flow obstruction
+collapse of airways under forced expiration.
Causes
 COPD
 Asthma
 Bronchiectasis
 Cystic Fibrosis
 Sarcoidosis (endobronchial)
 Chronic extrinsic allergic alveolitis
Spirometry: Obstructive Disease
Time, seconds
Volume,liters
Time, seconds
5
4
3
2
1
1 2 3 4 5 6
FEV1 = 1.8L
FVC = 3.2L
FEV1/FVC = 0.56
Normal
Obstructive
Graphs: Obstructive Abnormality
Coving of the expiratory loop
towards lower lung volumes
Reduced forced expiratory volume
in the first second (FEV1)
Severity
Post bronchodilator
FEV1
(% of predicted value)
Mild airflow obstruction > 80%
Moderate airflow
obstruction
79-50%
Severe airflow obstruction <30 – 49%
V. Severe airflow
obstruction
<30%
Measuring Reversibility of Airflow
Obstruction
 To measure the degree of reversibility of airflow
obstruction, perform spirometry before and 10
to 15 minutes after administering a
bronchodilator by metered dose inhaler or
nebuliser
 Beta2
agonists (e.g. salbutamol) are generally
considered the benchmark bronchodilator
Obstructive with reversibility
 If you get a COPD picture (FEV1/FVC < 70% and
FEV1 <80%) but there is a good degree of
reversibility-
- If > 200ml, then more likely to be asthma than
COPD.
- If < 200ml, it could be a combination of
asthma and COPD or another diagnosis
too. (Go back to history, exam and other inv).
Spirometry For COPD
SYMPTOMS
chronic cough
shortness of breath
EXPOSURE TO RISK
FACTORS
tobacco
occupation
indoor/outdoor pollution
SPIROMETRY: Required to establish
diagnosis
GOLD 2018
sputum
GOLD 2018
Spirometry should be performed after the
administration of an adequate dose(400µg) of a short-
acting inhaled bronchodilator to minimize variability.
A post-bronchodilator FEV1/FVC < 0.70 confirms
the presence of airflow limitation.
Where possible, values should be compared to age-
related normal values to avoid over diagnosis of COPD in
the elderly.
GOLD
Classification of Severity of Airflow
Limitation in COPD*
In patients with FEV1/FVC < 0.70 -
GOLD 1: Mild FEV1 > 80% predicted
GOLD 2: Moderate 50% < FEV1 < 80% predicted
GOLD 3: Severe 30% < FEV1 < 50% predicted
GOLD 4: Very Severe FEV1 < 30% predicted
*Based on Post-Bronchodilator FEV1
Division of lung volumes in normal subjects
and patients with COPD
T L C
IC
F R C
R V
N o rm a l C O P D
R V
VOLUME
T L C
IC
F R C
Spirometry for Asthma
Restrictive defects
 FEV1/FVC Ratio normal i.e. >70%
 Both FEV1 & FVC reduced(But no text says below
what level)
Mechanism-Reduction in all lung volumes
and reduced lung compliance.
 Causes
 Intrinsic - Interstitial lung diseases
 Extrinsic - Kyphoscoliosis, Ankylosing spondylitis,
Muscular dystrophies, Diffuse pleural thickening
Spirometry: Restrictive Disease
Volume,liters
Time, seconds
FEV1 = 1.9L
FVC = 2.0L
FEV1/FVC = 0.95
1 2 3 4 5 6
5
4
3
2
1
Normal
Restrictive
Graphs: Restrictive Abnormality
Tall narrow graph
Reduced flow,
miniature graph
Categorisation of restriction.
VC or TLC- % predicted
 Normal ≥ 81
 Mild restriction 66 - 80
 Moderate restriction 51 - 65
 Severe restriction ≤ 50
Mixed Obstructive/Restrictive
 FEV1: % predicted < 80%
 FVC: % predicted < 80%
 FEV1 /FVC: < 70
Mixed Obstructive and Restrictive
Restrictive and mixed obstructive-restrictive are difficult to diagnose by
spirometry alone; full respiratory function tests are usually required (e.g.,
body plethysmography, etc)
Volume,liters
Time, seconds
FEV1 = 0.5L
FVC = 1.5L
FEV1/FVC = 0.30
Normal
Obstructive - Restrictive
FEV1/FVC ratio
(Post bronchodilator)
Normal
FEV1
Normal
spirometry
Normal FEV1 reduced
Look at FVC
Restrictive defect
FVC reduced
Reduced (<70%)
Obstructive
defect
Points to remember in interpretation
 It is impossible to diagnose a respiratory condition
using spirometry alone. History & exam very
important. Think about serial PEFRs, CXR etc too.
 If the clinical picture and spirometry findings don’t
quite fit together well, question the diagnosis.
 If the symptoms are out of keeping with the
spirometry results -question the diagnosis.
Conclusions
 Spirometry defines obstructive and restrictive lung
diseases
 Highly reproducible test
 Needs to be performed accurately to ensure useful
data
 Courses available to train operators
 Highly valuable in the clinical setting
spirometry is like the
ECG of lungs
Thank you
Complications
 Syncope, dizziness, light headedness
 Pneumothorax
 Chest pain
 Coughing
 Bronchospasm
 Contraction of infection
Severe COPD
A
a
A
a
A
a
A
a
Case 1
Case 2
Pulmonary Fibrosis (Asbestosis) A
A
A
A
a
Case 3
?Severe COPD (with reversibility)
But history very important in this one
A
a
A
a
A
a
A
a
Case 4
Bronchiectasis(but could easily be Asthma or COPD with
reversibility)
A
A
A
A
A
A
Case 5
Idiopathic Pulmonary Fibrosis
A
A
Case 6
Idiopathic Pulmonary Fibrosis
Case 7
A
a
A
a
Muscular dystrophy
Typical expiratory spirograms and flow-
volume loops
Volume
T im e
O b s tr u c t io n
Volume
T im e
R e s tr ic tio n
Volume
T im e
M ix e dFlow
V o lu m e
Flow
V o lu m e
Flow
V o lu m e
N o r m a l ( ? )
A b n o r m a l v e n t ila t o r y f u n c t io n
S p ir o m e tr y p e r f o r m e d

More Related Content

What's hot

Dlco/tlco
Dlco/tlcoDlco/tlco
Dlco/tlco
Tanveer Fahim
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
Chetan Ganteppanavar
 
Ventilator Induced Lung Injury
Ventilator Induced Lung InjuryVentilator Induced Lung Injury
Ventilator Induced Lung Injury
Dr.Mahmoud Abbas
 
Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsGamal Agmy
 
Non Invasive Ventilation (NIV)
Non Invasive Ventilation (NIV)Non Invasive Ventilation (NIV)
Non Invasive Ventilation (NIV)
Prakhar Agarwal
 
Basic Of Mechanical Ventilation
Basic Of Mechanical VentilationBasic Of Mechanical Ventilation
Basic Of Mechanical VentilationDang Thanh Tuan
 
High flow nasal cannula (hfnc) linkden
High flow nasal cannula (hfnc) linkdenHigh flow nasal cannula (hfnc) linkden
High flow nasal cannula (hfnc) linkden
Ahmed AlGahtani, RRT
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT Khalid
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
Ashraf ElAdawy
 
Spirometry
SpirometrySpirometry
Spirometry
mahadairy
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing ppt
Waseem MD abdul
 
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function TestInterpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
DrSuman Roy
 
Mechenical ventilation
Mechenical ventilationMechenical ventilation
Mechenical ventilation
YouNHealth.Com
 
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
Maher AlQuaimi
 
Weaning from mechanical Ventilation
Weaning from mechanical   VentilationWeaning from mechanical   Ventilation
Weaning from mechanical Ventilation
Mohammad Abdeljawad
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
Smruti Patanaik
 

What's hot (20)

Dlco/tlco
Dlco/tlcoDlco/tlco
Dlco/tlco
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
Ventilator Induced Lung Injury
Ventilator Induced Lung InjuryVentilator Induced Lung Injury
Ventilator Induced Lung Injury
 
Pft 10.12.14
Pft 10.12.14Pft 10.12.14
Pft 10.12.14
 
Simple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function testsSimple Interpretation of Pulmonary Function tests
Simple Interpretation of Pulmonary Function tests
 
Non Invasive Ventilation (NIV)
Non Invasive Ventilation (NIV)Non Invasive Ventilation (NIV)
Non Invasive Ventilation (NIV)
 
Cpap
CpapCpap
Cpap
 
Basic Of Mechanical Ventilation
Basic Of Mechanical VentilationBasic Of Mechanical Ventilation
Basic Of Mechanical Ventilation
 
High flow nasal cannula (hfnc) linkden
High flow nasal cannula (hfnc) linkdenHigh flow nasal cannula (hfnc) linkden
High flow nasal cannula (hfnc) linkden
 
Interpretation OF PFT
Interpretation OF PFT		Interpretation OF PFT
Interpretation OF PFT
 
Spirometry Basics
Spirometry BasicsSpirometry Basics
Spirometry Basics
 
Spirometry
SpirometrySpirometry
Spirometry
 
Pft
PftPft
Pft
 
Broncho provocation testing ppt
Broncho provocation testing pptBroncho provocation testing ppt
Broncho provocation testing ppt
 
Interpretation of Pulmonary Function Test
Interpretation of Pulmonary Function TestInterpretation of Pulmonary Function Test
Interpretation of Pulmonary Function Test
 
Mechenical ventilation
Mechenical ventilationMechenical ventilation
Mechenical ventilation
 
pneumothorax in ICU
pneumothorax in ICUpneumothorax in ICU
pneumothorax in ICU
 
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
High flow nasal cannula (hfnc) by Tarfa Al-Sabhan
 
Weaning from mechanical Ventilation
Weaning from mechanical   VentilationWeaning from mechanical   Ventilation
Weaning from mechanical Ventilation
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
 

Similar to simplyfying spirometry

Diagnosis of COPD
Diagnosis of COPDDiagnosis of COPD
Diagnosis of COPDGamal Agmy
 
thoracicanesthesia-191114091229.pptx
thoracicanesthesia-191114091229.pptxthoracicanesthesia-191114091229.pptx
thoracicanesthesia-191114091229.pptx
AkmalFahrezzy1
 
Thoracic anesthesia and One Lung ventilation
Thoracic anesthesia and One Lung ventilationThoracic anesthesia and One Lung ventilation
Thoracic anesthesia and One Lung ventilation
Wasihun Aragie
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPD
Gamal Agmy
 
Copd introduction and pft
Copd introduction  and pftCopd introduction  and pft
Copd introduction and pft
prash258
 
Chronic obstructive pulmonary disease by aminu arzet
Chronic obstructive pulmonary disease by aminu arzetChronic obstructive pulmonary disease by aminu arzet
Chronic obstructive pulmonary disease by aminu arzet
AminuArzet
 
Pulmonary function testing
Pulmonary function testingPulmonary function testing
Pulmonary function testing
aljamhori teaching hospital
 
COPD Session 2
COPD Session 2COPD Session 2
COPD Session 2Gamal Agmy
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleem
TASLEEM ARIF
 
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJDPFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
SrijjanChauhan
 
My presentation
My presentationMy presentation
My presentation
Ghada Bashandy
 
Thoracic anaesthesia One lung ventilation
Thoracic anaesthesia  One lung ventilationThoracic anaesthesia  One lung ventilation
Thoracic anaesthesia One lung ventilation
Gaurav Joshi
 
Interpretation of pulmonary function tests.a practical guide
Interpretation of pulmonary function tests.a practical guideInterpretation of pulmonary function tests.a practical guide
Interpretation of pulmonary function tests.a practical guide
SoM
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)rsd8106
 
Asthma and copd overlap syndrome (acos) tst edited ramathibodi
Asthma and copd overlap syndrome (acos) tst edited ramathibodiAsthma and copd overlap syndrome (acos) tst edited ramathibodi
Asthma and copd overlap syndrome (acos) tst edited ramathibodi
Theerasuk Kawamatawong
 
COPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptxCOPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptx
LeelawathyPandian
 
Pulmonary Function Testing 2023.pdf
Pulmonary Function Testing 2023.pdfPulmonary Function Testing 2023.pdf
Pulmonary Function Testing 2023.pdf
aljamhori teaching hospital
 
COPD Lecture 9 spirometry of obstructive lung diseases
COPD Lecture 9  spirometry of obstructive lung diseasesCOPD Lecture 9  spirometry of obstructive lung diseases
COPD Lecture 9 spirometry of obstructive lung diseases
Dr.Mahmoud Abbas
 

Similar to simplyfying spirometry (20)

Copd
Copd Copd
Copd
 
Diagnosis of COPD
Diagnosis of COPDDiagnosis of COPD
Diagnosis of COPD
 
thoracicanesthesia-191114091229.pptx
thoracicanesthesia-191114091229.pptxthoracicanesthesia-191114091229.pptx
thoracicanesthesia-191114091229.pptx
 
Thoracic anesthesia and One Lung ventilation
Thoracic anesthesia and One Lung ventilationThoracic anesthesia and One Lung ventilation
Thoracic anesthesia and One Lung ventilation
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPD
 
Copd introduction and pft
Copd introduction  and pftCopd introduction  and pft
Copd introduction and pft
 
Chronic obstructive pulmonary disease by aminu arzet
Chronic obstructive pulmonary disease by aminu arzetChronic obstructive pulmonary disease by aminu arzet
Chronic obstructive pulmonary disease by aminu arzet
 
Pulmonary function testing
Pulmonary function testingPulmonary function testing
Pulmonary function testing
 
COPD Session 2
COPD Session 2COPD Session 2
COPD Session 2
 
Spirometry by dr tasleem
Spirometry by dr tasleemSpirometry by dr tasleem
Spirometry by dr tasleem
 
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJDPFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
PFT JJDWIJDWJWDIJIWDJIWJDIWJIDJIWJIDIWJIDJWIJD
 
My presentation
My presentationMy presentation
My presentation
 
Thoracic anaesthesia One lung ventilation
Thoracic anaesthesia  One lung ventilationThoracic anaesthesia  One lung ventilation
Thoracic anaesthesia One lung ventilation
 
Interpretation of pulmonary function tests.a practical guide
Interpretation of pulmonary function tests.a practical guideInterpretation of pulmonary function tests.a practical guide
Interpretation of pulmonary function tests.a practical guide
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)
 
Asthma and copd overlap syndrome (acos) tst edited ramathibodi
Asthma and copd overlap syndrome (acos) tst edited ramathibodiAsthma and copd overlap syndrome (acos) tst edited ramathibodi
Asthma and copd overlap syndrome (acos) tst edited ramathibodi
 
COPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptxCOPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptx
 
Pulmonary Function Testing 2023.pdf
Pulmonary Function Testing 2023.pdfPulmonary Function Testing 2023.pdf
Pulmonary Function Testing 2023.pdf
 
Copd 2006
Copd 2006Copd 2006
Copd 2006
 
COPD Lecture 9 spirometry of obstructive lung diseases
COPD Lecture 9  spirometry of obstructive lung diseasesCOPD Lecture 9  spirometry of obstructive lung diseases
COPD Lecture 9 spirometry of obstructive lung diseases
 

More from Kumar Utsav

newer updates in COPD: overview 2022.pptx
newer updates in COPD: overview 2022.pptxnewer updates in COPD: overview 2022.pptx
newer updates in COPD: overview 2022.pptx
Kumar Utsav
 
Nutrition in COPD.pptx
Nutrition in COPD.pptxNutrition in COPD.pptx
Nutrition in COPD.pptx
Kumar Utsav
 
NEWER UPDATE IN COVID MANAGEMENT.pptx
NEWER UPDATE IN COVID MANAGEMENT.pptxNEWER UPDATE IN COVID MANAGEMENT.pptx
NEWER UPDATE IN COVID MANAGEMENT.pptx
Kumar Utsav
 
MANAGMENT OF Tubercular preventive treatment
MANAGMENT OF Tubercular preventive treatment MANAGMENT OF Tubercular preventive treatment
MANAGMENT OF Tubercular preventive treatment
Kumar Utsav
 
VENTILATORY STRATEGY IN HEART FAILURE
VENTILATORY STRATEGY IN HEART FAILUREVENTILATORY STRATEGY IN HEART FAILURE
VENTILATORY STRATEGY IN HEART FAILURE
Kumar Utsav
 
lung cancer biomarkers
lung cancer biomarkerslung cancer biomarkers
lung cancer biomarkers
Kumar Utsav
 
Predictive biomarkers for lung cancer
Predictive biomarkers for lung cancerPredictive biomarkers for lung cancer
Predictive biomarkers for lung cancer
Kumar Utsav
 
Judicious use of antibiotics
Judicious use of antibioticsJudicious use of antibiotics
Judicious use of antibiotics
Kumar Utsav
 
Gina 2017 update
Gina 2017 update Gina 2017 update
Gina 2017 update
Kumar Utsav
 

More from Kumar Utsav (9)

newer updates in COPD: overview 2022.pptx
newer updates in COPD: overview 2022.pptxnewer updates in COPD: overview 2022.pptx
newer updates in COPD: overview 2022.pptx
 
Nutrition in COPD.pptx
Nutrition in COPD.pptxNutrition in COPD.pptx
Nutrition in COPD.pptx
 
NEWER UPDATE IN COVID MANAGEMENT.pptx
NEWER UPDATE IN COVID MANAGEMENT.pptxNEWER UPDATE IN COVID MANAGEMENT.pptx
NEWER UPDATE IN COVID MANAGEMENT.pptx
 
MANAGMENT OF Tubercular preventive treatment
MANAGMENT OF Tubercular preventive treatment MANAGMENT OF Tubercular preventive treatment
MANAGMENT OF Tubercular preventive treatment
 
VENTILATORY STRATEGY IN HEART FAILURE
VENTILATORY STRATEGY IN HEART FAILUREVENTILATORY STRATEGY IN HEART FAILURE
VENTILATORY STRATEGY IN HEART FAILURE
 
lung cancer biomarkers
lung cancer biomarkerslung cancer biomarkers
lung cancer biomarkers
 
Predictive biomarkers for lung cancer
Predictive biomarkers for lung cancerPredictive biomarkers for lung cancer
Predictive biomarkers for lung cancer
 
Judicious use of antibiotics
Judicious use of antibioticsJudicious use of antibiotics
Judicious use of antibiotics
 
Gina 2017 update
Gina 2017 update Gina 2017 update
Gina 2017 update
 

Recently uploaded

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

simplyfying spirometry

  • 1.
  • 4. WHY DO WE NEED SPIROMETRY…
  • 5.  Spirometry is a method of assessing lung function by measuring the volume of air the patient can expel from the lungs after a maximal inspiration.  A simple and safe test that measures lung function with a graphical display. What is Spirometry?
  • 6. spirometry is like the ECG of lungs
  • 7. Eur Respir J 2005; 25:587-588 Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? J. Sunyer1 and C. S. Ulrik2 LUNG HEALTH STUDY
  • 8. Chest. 2005;127:1952-1959 The Relationship Between Reduced Lung Function and Cardiovascular Mortality A Population-Based Study Don D. Sin, MD, MPH, FCCP; LieLing Wu, MSc and S. F. Paul Man, MD Every 10% decrease in FEV1 leads to – 14% Increase in all cause mortality 28% increase in Cardio-Vascular mortality COPD is powerful independent risk factor for Cardio-Vascular mortality LUNG HEALTH STUDY
  • 9. In fact, approximately 50% patients of COPD have ischemic heart disease as the primary cause of hospitalization. COPD & CVD: Chest. 2005;127:1952-1959 LUNG HEALTH STUDY
  • 10. Why should every doctor know about spirometry? More than half of the population of India suffer from respiratory disease or are the potential patients of these diseases Therefore any doctor involved in care of asthma, COPD or pulmonary fibrosis should understand the basics of pulmonary function testing
  • 11. Why do physicians not do spirometry ?  Don’t ever think about it  Too busy  Feel the test is complex  Don’t know what to ask for in the spirogram  Time consuming  Not cost effective  Results don’t affect treatment
  • 12. Indications  Diagnosis of obstructive & restrictive lung diseases  To screen people at risk of pulmonary diseases  To assess preoperative risk  To assess prognosis  To assess therapeutic interventions  To assess patients as part of a rehabilitation program  Epidemiologic surveys for pulmonary diseases
  • 13. Contraindications:  Within 6 weeks since the last exacerbation.  Recent MI less than 3-6 months ago.  Unstable angina in last 24 hours.  Haemoptysis of unknown origin.  Recent eye surgery less than 3-6 months.  Abdominal surgery within last 3-6 months.  Recent CVA less than 3-6 months.  Diagnosis of Tuberculosis unless special precautions used.  Current chest infection or within in last 6 weeks.  Current chest pain with no diagnosis.  Pulmonary embolism (PE) within last 3-6 months.  Ear infection.  Spontaneous pneumothorax.  Aortic aneurysm.
  • 14. DONT’S  Smoking (1 hour prior)  Consumption of alcohol (4 hours prior)  Vigorous exercise (30 minutes prior)  Wearing tight clothes.  Eating a substantial meal (at least 2 hours prior)  Test should be performed when the patient is clinically stable and free from infection.  Drinking fluids containing caffeine (12 hours prior)
  • 15. Withholding bronchodilators (ARTP) Inhaled bronchodilators Duration of action (hours) Short-acting 4 to 8 Long-acting 24 Anticholinergics 6 Oral short-acting bronchodilators 8 Sustained release β2 agonists 24 Theophylline Twice-daily preparations 24 Once-daily preparations 48
  • 16. Definitions  Forced Expiratory Manoeuvre (FEM) The patient takes a maximal deep breath , then blows out as hard as possible until the lungs feel completely empty. From this the following parameters are calculated:  FEV1 Volume of gas expired from the lungs in the 1st second of a FEM  FVC Total volume of gas expired from the lungs during a FEM  FER FEV1/FVC
  • 18. Interpretation of Spirometry Step 1. Look at the Flow-Volume loop Step 2. Look at FEV1/FVC ratio Step 3. Look at FVC Step 4. Look at FEV1 >75% Step 5. Look at FEF25-75%
  • 19.
  • 20.
  • 21.
  • 22.
  • 23. Criteria for Normal Post-bronchodilator Spirometry  FEV1: % predicted > 80%  FVC: % predicted > 80%  FEV1/FVC: > 70
  • 24. Two basic types of pulmonary function abnormalities are described using the basic spirometric parameters: Obstructive and Restrictive
  • 25. Obstructive defects  FEV1/ FVC Ratio < 70%  FEV1 <80%(Post bronchodilator) Mechanism Airway damage and flow obstruction +collapse of airways under forced expiration. Causes  COPD  Asthma  Bronchiectasis  Cystic Fibrosis  Sarcoidosis (endobronchial)  Chronic extrinsic allergic alveolitis
  • 26. Spirometry: Obstructive Disease Time, seconds Volume,liters Time, seconds 5 4 3 2 1 1 2 3 4 5 6 FEV1 = 1.8L FVC = 3.2L FEV1/FVC = 0.56 Normal Obstructive
  • 27. Graphs: Obstructive Abnormality Coving of the expiratory loop towards lower lung volumes Reduced forced expiratory volume in the first second (FEV1)
  • 28. Severity Post bronchodilator FEV1 (% of predicted value) Mild airflow obstruction > 80% Moderate airflow obstruction 79-50% Severe airflow obstruction <30 – 49% V. Severe airflow obstruction <30%
  • 29. Measuring Reversibility of Airflow Obstruction  To measure the degree of reversibility of airflow obstruction, perform spirometry before and 10 to 15 minutes after administering a bronchodilator by metered dose inhaler or nebuliser  Beta2 agonists (e.g. salbutamol) are generally considered the benchmark bronchodilator
  • 30. Obstructive with reversibility  If you get a COPD picture (FEV1/FVC < 70% and FEV1 <80%) but there is a good degree of reversibility- - If > 200ml, then more likely to be asthma than COPD. - If < 200ml, it could be a combination of asthma and COPD or another diagnosis too. (Go back to history, exam and other inv).
  • 32. SYMPTOMS chronic cough shortness of breath EXPOSURE TO RISK FACTORS tobacco occupation indoor/outdoor pollution SPIROMETRY: Required to establish diagnosis GOLD 2018 sputum
  • 33. GOLD 2018 Spirometry should be performed after the administration of an adequate dose(400µg) of a short- acting inhaled bronchodilator to minimize variability. A post-bronchodilator FEV1/FVC < 0.70 confirms the presence of airflow limitation. Where possible, values should be compared to age- related normal values to avoid over diagnosis of COPD in the elderly.
  • 34. GOLD Classification of Severity of Airflow Limitation in COPD* In patients with FEV1/FVC < 0.70 - GOLD 1: Mild FEV1 > 80% predicted GOLD 2: Moderate 50% < FEV1 < 80% predicted GOLD 3: Severe 30% < FEV1 < 50% predicted GOLD 4: Very Severe FEV1 < 30% predicted *Based on Post-Bronchodilator FEV1
  • 35. Division of lung volumes in normal subjects and patients with COPD T L C IC F R C R V N o rm a l C O P D R V VOLUME T L C IC F R C
  • 37.
  • 38. Restrictive defects  FEV1/FVC Ratio normal i.e. >70%  Both FEV1 & FVC reduced(But no text says below what level) Mechanism-Reduction in all lung volumes and reduced lung compliance.  Causes  Intrinsic - Interstitial lung diseases  Extrinsic - Kyphoscoliosis, Ankylosing spondylitis, Muscular dystrophies, Diffuse pleural thickening
  • 39. Spirometry: Restrictive Disease Volume,liters Time, seconds FEV1 = 1.9L FVC = 2.0L FEV1/FVC = 0.95 1 2 3 4 5 6 5 4 3 2 1 Normal Restrictive
  • 40. Graphs: Restrictive Abnormality Tall narrow graph Reduced flow, miniature graph
  • 41. Categorisation of restriction. VC or TLC- % predicted  Normal ≥ 81  Mild restriction 66 - 80  Moderate restriction 51 - 65  Severe restriction ≤ 50
  • 42. Mixed Obstructive/Restrictive  FEV1: % predicted < 80%  FVC: % predicted < 80%  FEV1 /FVC: < 70
  • 43. Mixed Obstructive and Restrictive Restrictive and mixed obstructive-restrictive are difficult to diagnose by spirometry alone; full respiratory function tests are usually required (e.g., body plethysmography, etc) Volume,liters Time, seconds FEV1 = 0.5L FVC = 1.5L FEV1/FVC = 0.30 Normal Obstructive - Restrictive
  • 44. FEV1/FVC ratio (Post bronchodilator) Normal FEV1 Normal spirometry Normal FEV1 reduced Look at FVC Restrictive defect FVC reduced Reduced (<70%) Obstructive defect
  • 45. Points to remember in interpretation  It is impossible to diagnose a respiratory condition using spirometry alone. History & exam very important. Think about serial PEFRs, CXR etc too.  If the clinical picture and spirometry findings don’t quite fit together well, question the diagnosis.  If the symptoms are out of keeping with the spirometry results -question the diagnosis.
  • 46. Conclusions  Spirometry defines obstructive and restrictive lung diseases  Highly reproducible test  Needs to be performed accurately to ensure useful data  Courses available to train operators  Highly valuable in the clinical setting
  • 47.
  • 48. spirometry is like the ECG of lungs
  • 50. Complications  Syncope, dizziness, light headedness  Pneumothorax  Chest pain  Coughing  Bronchospasm  Contraction of infection
  • 52. Case 2 Pulmonary Fibrosis (Asbestosis) A A A A a
  • 53. Case 3 ?Severe COPD (with reversibility) But history very important in this one A a A a A a A a
  • 54. Case 4 Bronchiectasis(but could easily be Asthma or COPD with reversibility) A A A A A A
  • 58.
  • 59. Typical expiratory spirograms and flow- volume loops Volume T im e O b s tr u c t io n Volume T im e R e s tr ic tio n Volume T im e M ix e dFlow V o lu m e Flow V o lu m e Flow V o lu m e N o r m a l ( ? ) A b n o r m a l v e n t ila t o r y f u n c t io n S p ir o m e tr y p e r f o r m e d

Editor's Notes

  1. Assesses dynamic flow within the airways Airway calibre Lung compliance
  2. (Increases Intraocular,Intrathoracic, Intra-abd and Intracranial pressure)
  3. Basic spirometry involves only the measurement of forced vital capacity (FVC) and the forced expired volume in the first second (FEV1). The ratio between the two is a self-controlled statistic which tells if obstruction is present. FVC and FEV1 can be measured against predicted values. PEFR is not reproducible enough measurement for accurate diagnosis, but may be used more for following progress with asthma. FEF 25-75% is a measurement of smaller airway function but this measurement is usually not clinically useful.
  4. Some texts suggest its the narrowing of the airways and some suggest it could be the collapse of the airways when air is expelled forcefully that impedes the expiration. In reality , it could be both to some extent.
  5. Note the significant increases in total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV), as well as the increase in the ratio of FRC to TLC and of RV to TLC. Note also the fall in inspiratory capcity (IC